Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded a site revision label v3.4.1; removed the funding-status notice and the earlier revision label v3.4.0.SummaryDifference0.1%

- Check12 days agoChange DetectedLocation entry for India (122001) changed from Gurgaon to Gūrgaon, adding a macron to the city name. This aligns the listing with localized spelling and ensures consistent site identification for recruitment and mapping.SummaryDifference0.0%

- Check19 days agoChange DetectedThe study's location count updated to 263 locations (from 264), affecting the recruitment site list and related location details; the page now includes a 'Show glossary' option.SummaryDifference0.2%

- Check26 days agoChange DetectedThe page version label was updated from v3.3.3 to v3.3.4, a minor metadata change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedNew locations added: Ho Chi Minh City (Vietnam), Edinburgh (UK), Maumee (Ohio), Ann Arbor (Michigan), and Tainan (Taiwan). Total sites increased from 260 to 264, with the Tainan site previously removed and later re-added.SummaryDifference0.4%

- Check55 days agoChange DetectedRemoved the previous state/province location listings and introduced a consolidated Locations section, adding new sites including Gurgaon, India, and locations across the US and Canada.SummaryDifference0.8%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.